Journals
Books
Articles by keyword inhibitor
FUNCTIONAL STUDY OF THE NEW SYNTHETIC THROMBIN INHIBITOR HC-019S-IOC IN VITRO AND ITS TRIAL IN VIVO AS A PART OF A PLASMA SUBSTITUTING SOLUTION IN MODEL OF HEMODILUTION IN RATS
E.I. Sinauridze, S.S. Surov, I.V. Gribkova, A.S. Gorbatenko, M.Y. Monakov, F.I. Ataullakhanov
Matrix metalloproteinases and clinico-morphological characteristic of ovarian neoplasms
N.E. Kushlinsky, E.S. Gershtein, N.V. Levkina, D.N. Kushlinsky, I.V. Tereshkina, K.P. Laktionov K.P., L.V. Adamiyan
NEW DIRECT LOW MOLECULAR WEIGHT SYNTHETIC THROMBIN INHIBITORS
E.I. Sinauridze, A.N. Romanov, O.A. Kondakova, I.V. Gribkova, S.S. Surov, A.S. Gorbatenko, Y.V. Kuznetsov, A.A. Bogolyubov, V.B. Sulimov, F.I. Ataullakhanov
Interaction Photoraised Oxifenil Radicals with Ions of Cobalt and Iron
V.I. Porhun, V.A. Navrotskii, L.N. Rygalov
DIRECT ELECTROMETRIC DEFINITION OF EFFICIENCY CORROSION INHIBITORS USING THE PROCESSES OF STEADY-STATE DIFFUSION
V.V. Leonov, M.Yu. Dolomatov, V.V. Ragulin, A.A. Daminov
Endothelin-converting enzyme inhibitor promotes renovascular hypertension development in rats (1 kidney-1 clip Goldblatt model)
M.E. Ilatovskaya, S.I. Sofronova, V.F. Pozdnev, N.A. Medvedeva
Matrix Metalloproteinases in Ovarian Cancer Patients
E.S. Gershtein, N.V. Levkina, I.V. Tereshkina, V.D. Ermilova, D.N. Kushlinsky, V.B. Nosov, L.V. Adamian, K.P. Laktionov
Prognostic significance of urokinase and tissue type plasminogen activators and their type 1 inhibitor in the tumors of colorectal cancer oatients: results of 10 years follow-up
E.S. Gershtein, V.V. Prorokov, N.E. Kushlinsky
Clinical Prospects of Matrix Metalloproteinases 2, 7, 9 and Their Tissue Inhibitors Study in Colorectal Cancer Patients
E.A. Korotkova, E.S. Gershtein, V.V. Prorokov
Perspectives in creating anticancer drugs against urokinase-type plasminogen activator system
I.B. Beloglazova, Zh.A. Akopyan, M.N. Karagyaur, O.S. Plekhanova, E.V. Syomina, D.V. Stambolsky
Use of the capillary electrophoresis for studying of pharmacokinetics of new SYK-kinazy inhibitor
S.P. Senchenko - Ph.D. (Pharm.), Associate Professor, Department of Pharmaceutical and Toxicological Chemistry, Pyatigorsk Medico-Pharmaceutical Institute-Branch to Volgograd State Medical University. E-mail: asp_nauka@mail.ru
H.G. Chilov - Ph.D. (Chem.), Senior Research Scientist, N.D. Zelinsky of Institute of Organic Chemistry, Russian Academy of Sciences, General Director of LLS «Molekulyarnye Tekhnologii» (Moscow)
F.N. Novikov - Ph.D. (Chem.), Research Scientist, N.D. Zelinsky of Institute of Organic Chemistry, Russian Academy of Sciences (Moscow)
A.Y. Terekhov - Ph.D. (Pharm.), Associate Professor, Department of Morphology and Pathology, Pyatigorsk Medico-Pharmaceutical Institute-Branch to Volgograd State Medical University
Medicinal plants as the sources of natural «quorum sensing» inhibitors
D.G. Deryabin - Dr.Sc. (Med.), Professor, Head of the Microbiological Department, Orenburg State University. E-mail: dgderyabin@yandex.ru
A.A. Tolmacheva - Post-graduate Student, Microbiological Department, Orenburg State University. E-mail: annatolmacheva56@gmail.com
The study of peculiarities of antibiotic streptolydigin action on bacterial RNA polymerase
S.D. Zorov - Ph.D. (Biol.), Senior Lecturer, Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, Russia. E-mail: zorov@inbox.ru
The use of vascular endothelial growth factor inhibitors in patients with proliferative diabetic retinopathy

V.Yu. Evgrafov1, G.R. Kudasheva2

1,2 Pirogov Russian National Research Medical University (Moscow, Russia)